Top

Journal of Clinical Immunology

Published in:

01-07-2021 | Primary Immunodeficiency | Letter to Editor

Recurrent Chronic HEV in Severe Combined Immunodeficiency

Authors: Prebashan Moodley, Andrew F. Whyte, Ashwin Dhanda

Published in: Journal of Clinical Immunology | Issue 5/2021

Excerpt

To the Editor …

Dalton HR, Kamar N, Baylis SA, Moradpour D, Wedemeyer H, Negro F. EASL Clinical Practice Guidelines on hepatitis E virus infection. Journal of Hepatology. 2018;68(6). https://doi.org/10.1016/j.jhep.2018.03.005.

Suneetha PV, Pischke S, Schlaphoff V, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology. 2012;55(3). https://doi.org/10.1002/hep.24738.

Guerra JA de AA, Kampa KC, Morsoletto DGB, Junior AP, Ivantes CAP. Hepatitis E: a literature review. Journal of Clinical and Translational Hepatology. 2017;5(4). https://doi.org/10.14218/JCTH.2017.00012.

Pischke S, Peron JM, von Wulffen M, et al. Chronic hepatitis e in rheumatology and internal medicine patients: a retrospective multicenter European cohort study. Viruses. 2019;11(2). https://doi.org/10.3390/v11020186.

Frucht DM, Gadina M, Jagadeesh GJ, et al. Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes and Immunity. 2001;2(8). https://doi.org/10.1038/sj.gene.6363802.

Title: Recurrent Chronic HEV in Severe Combined Immunodeficiency
Authors: Prebashan Moodley
Andrew F. Whyte
Ashwin Dhanda
Publication date: 01-07-2021
Publisher: Springer US
Keywords: Primary Immunodeficiency
Ribavirin
Immunodeficiency
Bowen's Disease
Hepatitis E
Published in: Journal of Clinical Immunology / Issue 5/2021
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-021-00999-4

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Recurrent Chronic HEV in Severe Combined Immunodeficiency

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2021

Gene Editing Rescues In vitro T Cell Development of RAG2-Deficient Induced Pluripotent Stem Cells in an Artificial Thymic Organoid System

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain

Novel ORAI1 Mutation Disrupts Channel Trafficking Resulting in Combined Immunodeficiency

Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience

Two Novel Homozygous Mutations in Phosphoglucomutase 3 Leading to Severe Combined Immunodeficiency, Skeletal Dysplasia, and Malformations

Novel CD3Z and CD3E Deficiency in Two Unrelated Females

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page